Latest Prescription Drugs news
FDA Approves First Treatment for Thyroid Eye Disease
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
EHA: Adding Pirtobrutinib to Venetoclax-Rituximab Ups PFS in Chronic Lymphocytic Leukemia
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Recommendations Updated for Management of Anemia in CKD 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Initial Rx Length Tied to Long-Term Use of Z-Drugs Related Articles
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Monthly Specialist Briefings
Stay Connected
